Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02049515
Title A Phase 3 Extension Study of IPI-145 and Ofatumumab in Patients With CLL/SLL Previously Enrolled in Study IPI-145-07
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Infinity Pharmaceuticals, Inc.
Indications

chronic lymphocytic leukemia

Therapies

Ofatumumab

Duvelisib

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | BEL | AUT

Facility Status City State Zip Country Details
La Jolla California 92093-0698 United States Details
Denver Colorado 80218 United States Details
Fort Myers Florida 33916 United States Details
Saint Petersburg Florida 33705 United States Details
Boston Massachusetts 02114 United States Details
Boston Massachusetts 02115 United States Details
Saint Louis Missouri 63130 United States Details
Hackensack New Jersey 07601 United States Details
New Brunswick New Jersey 08903 United States Details
New York New York 10032 United States Details
New York New York 10065 United States Details
Cincinnati Ohio 45236 United States Details
Nashville Tennessee 37203 United States Details
Charlottesville Virginia 22903 United States Details
Bedford Park 5042 Australia Details
East Melbourne 3002 Australia Details
Melbourne 3058 Australia Details
Linz 4010 Austria Details
Vienna 1090 Austria Details
Wels 4600 Austria Details
Wien 1130 Austria Details
Bruxelles 1000 Belgium Details
Bruxelles 1200 Belgium Details
Gent 9000 Belgium Details
Leuven 3000 Belgium Details
Sint-Niklaas 9100 Belgium Details
Argenteuil Cedex 95107 France Details
Bobigny 93009 France Details
Bordeaux 33076 France Details
Caen 14033 France Details
Clermont Ferrand 63100 France Details
La Roche Sur Yon 85025 France Details
Limoges Cedex 87042 France Details
Nantes 44000 France Details
Rennes 35033 France Details
Vandœuvre-lès-Nancy 54511 France Details
Berlin 10707 Germany Details
Leer 26789 Germany Details
Ulm 89081 Germany Details
Budapest 1083 Hungary Details
Budapest 1122 Hungary Details
Debrecen 4032 Hungary Details
Gyor 9024 Hungary Details
Kaposvár 7400 Hungary Details
Pecs 7624 Hungary Details
Szeged 6725 Hungary Details
Catania 95124 Italy Details
Lecce 73100 Italy Details
Meldola 47014 Italy Details
Milano 20132 Italy Details
Milano 20162 Italy Details
Padova 35128 Italy Details
Ravenna 48121 Italy Details
Rimini 47923 Italy Details
Roma 00133 Italy Details
Auckland 1023 New Zealand Details
Palmerston North 4442 New Zealand Details
Barcelona 08035 Spain Details
Barcelona 08036 Spain Details
Barcelona 08041 Spain Details
Madrid 28033 Spain Details
Madrid 28050 Spain Details
Pamplona 31008 Spain Details
Bournemouth BH7 7DW United Kingdom Details
Leeds LS9 7TF United Kingdom Details
Manchester M20 4BX United Kingdom Details
Nottingham NG5 1PB United Kingdom Details
Oxford OX3 7JL United Kingdom Details
Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field